BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38925791)

  • 1. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
    Vaezi A; Healy T; Ebrahimi G; Rezvankhah S; Hashemi Shahraki A; Mirsaeidi M
    Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38925791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Therapy for Respiratory Infections: Opportunities and Challenges.
    Khosravi A; Chen Q; Echterhof A; Koff JL; Bollyky PL
    Lung; 2024 Jun; 202(3):223-232. PubMed ID: 38772946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
    Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
    Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phage therapy for respiratory infections].
    Mitropoulou G; Gijs PJ; Koutsokera A; Sauty A; Blanchon S; Csajka C; Brunet JF; Resch G; Guery B; Von Garnier C
    Rev Med Suisse; 2022 Nov; 18(804):2150-2156. PubMed ID: 36382975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.
    Mangalea MR; Duerkop BA
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Therapy for Multi-Drug Resistant Respiratory Tract Infections.
    Iszatt JJ; Larcombe AN; Chan HK; Stick SM; Garratt LW; Kicic A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen.
    Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L
    Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of bacteriophage therapy in the treatment of paediatric respiratory infections.
    Jones JD; Varghese D; Pabary R; Langley RJ
    Paediatr Respir Rev; 2022 Dec; 44():70-77. PubMed ID: 35241371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.